Ischemic stroke is responsible for many deaths and long-term disability world wide.
Development of effective therapy has been the target of intense research. Accumulating …

MicroRNAs (miRNAs) are short non-coding RNAs involved in post-trascriptional regulation
of gene expression and diverse biological activities. They are crucial for self-renewal and …

Extracellular vesicles (EVs) secreted by cells present an attractive strategy for developing
new therapies, but progress in the field is limited by several issues: The quality of the EVs …

Multipotent mesenchymal stromal cells (MSCs) have potential therapeutic benefit for the
treatment of neurological diseases and injury. MSCs interact with and alter brain …

Exosomes derived from bone mesenchymal stem cells (BMSC-Exos) are one of the main
factors responsible for the therapeutic effects of BMSCs. The study aimed to investigate …

Neurological disorders are a massive challenge for modern medicine. Apart from the fact
that this group of diseases is the second leading cause of death worldwide, the majority of …

Neurodegenerative disorders have become the leading cause of chronic pain and death.
Treatments available are not sufficient to help the patients as they only alleviate the …

The liver is the second largest organ in the human body and is responsible for several
functions that directly contribute to homeostasis. Hepatocytes are the main parenchymal …

The inherent poor regeneration capacity of nerve tissues, especially in the central nervous
system, poses a grand challenge for neural tissue engineering. After injuries, the local …

Overview MicroRNAs (miRNAs) have been implicated in neurodegenerative diseases
including Parkinson's disease and Alzheimer's disease (AD). Here, we evaluated the …